Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis

Summary

This study will explore the biologic activity of guanabenz in reducing bone turn over in solid tumor patients with bone metastasis. If successful, this repurposing of an already, generic drug could benefit patients faster than manufacturing a novel expensive compound.

Timeline

Start

2015-05-07

Primary completion

2016-06-08

Completion

2016-06-08

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual”

Drugs

Indications